Envista Holdings Corp. (NVST) News
Filter NVST News Items
NVST News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NVST News Highlights
- For NVST, its 30 day story count is now at 24.
- Over the past 23 days, the trend for NVST's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- BEAT, PDS and DUO are the most mentioned tickers in articles about NVST.
Latest NVST News From Around the Web
Below are the latest news stories about Envista Holdings Corp that investors may wish to consider to help them evaluate NVST as an investment opportunity.
Envista Announces Participation in Jefferies Virtual Dental SummitEnvista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Jefferies Virtual Dental Summit on Thursday, February 24th from 6:00 – 6:45 AM PST. |
Charles River (CRL) DSA Arm Sees Growth, Cell Supply SluggishThe acquisitions of Cognate BioServices and Vigene Biosciences contribute to the growth of Charles River's (CRL) Manufacturing Solutions arm. |
Henry Schein (HSIC) Up 10.1% Since Posting Q4 Earnings BeatHenry Schein (HSIC) stock rallies on strong fourth-quarter performance and bullish 2022 EPS guidance. |
Syneos Health (SYNH) Q4 Earnings Top Estimates, Margins DownSyneos Health (SYNH) reports better-than-expected earnings for the fourth quarter and strong performances by the Clinical Solutions and Commercial Solutions arms. |
Globus Medical (GMED) Q4 Earnings Top Estimates, Gross Margin UpStrength in Musculoskeletal Solutions and Enabling Technologies products drove Globus Medical's (GMED) Q4 revenues. |
Is Indivior PLC (INVVY) Outperforming Other Medical Stocks This Year?Here is how Indivior PLC (INVVY) and Envista (NVST) have performed compared to their sector so far this year. |
Henry Schein (HSIC) Q4 Earnings Top Estimates, Margins GrowRobust performances by all three operating businesses drove Henry Schein's (HSIC) Q4 revenues. |
Omnicell (OMCL) Q4 Earnings Miss Estimates, Revenues BeatRobust performance by the Product and Service segments is driving Omnicell's (OMCL) fourth-quarter top line. |
Envista Holdings Corporation's (NVST) CEO Amir Aghdaei on Q4 2021 Results - Earnings Call TranscriptEnvista Holdings Corporation (NVST) Q4 2021 Earnings Conference Call February 09, 2022 5:00 PM ET Company Participants Stephen Keller – Vice President of Investor Relations Amir Aghdaei – President and Chief Executive Officer Howard Yu – Chief Financial Officer Conference Call Participants Elizabeth Anderson – Evercore Jeff Johnson – Baird... |
Dermata, Innoviva top healthcare gainers; while InfuSystem, Seagen lead losers packGainers: Dermata Therapeutics DRMA +35%. Innoviva (INVA) +11%. Mainz Biomed (MYNZ) +9%. Regional Health Properties RHE +9%. Envista Holdings (NVST) +8%.Losers: InfuSystem |